93 related articles for article (PubMed ID: 18562736)
1. Perfusion MDCT enables early detection of therapeutic response to antiangiogenic therapy.
Sabir A; Schor-Bardach R; Wilcox CJ; Rahmanuddin S; Atkins MB; Kruskal JB; Signoretti S; Raptopoulos VD; Goldberg SN
AJR Am J Roentgenol; 2008 Jul; 191(1):133-9. PubMed ID: 18562736
[TBL] [Abstract][Full Text] [Related]
2. Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT.
Fournier LS; Oudard S; Thiam R; Trinquart L; Banu E; Medioni J; Balvay D; Chatellier G; Frija G; Cuenod CA
Radiology; 2010 Aug; 256(2):511-8. PubMed ID: 20551183
[TBL] [Abstract][Full Text] [Related]
3. Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.
Cyran CC; von Einem JC; Paprottka PM; Schwarz B; Ingrisch M; Dietrich O; Hinkel R; Bruns CJ; Clevert DA; Eschbach R; Reiser MF; Wintersperger BJ; Nikolaou K
Invest Radiol; 2012 Jan; 47(1):49-57. PubMed ID: 21934514
[TBL] [Abstract][Full Text] [Related]
4. Does arterial spin-labeling MR imaging-measured tumor perfusion correlate with renal cell cancer response to antiangiogenic therapy in a mouse model?
Schor-Bardach R; Alsop DC; Pedrosa I; Solazzo SA; Wang X; Marquis RP; Atkins MB; Regan M; Signoretti S; Lenkinski RE; Goldberg SN
Radiology; 2009 Jun; 251(3):731-42. PubMed ID: 19474376
[TBL] [Abstract][Full Text] [Related]
5. [Feasibility of volume perfusion CT (VPCT) imaging in antiangiogenic treatment of rabbit VX2 soft-tissue tumor].
Yang P; Feng XW; Ye ZX; Li XB; Hou Y; Liu YT; Xiao JY
Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):341-6. PubMed ID: 24054009
[TBL] [Abstract][Full Text] [Related]
6. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
Akisik MF; Sandrasegaran K; Bu G; Lin C; Hutchins GD; Chiorean EG
Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
[TBL] [Abstract][Full Text] [Related]
7. Quantitative contrast enhanced ultrasound and CT assessment of tumor response to antiangiogenic therapy in rats.
Pollard RE; Broumas AR; Wisner ER; Vekich SV; Ferrara KW
Ultrasound Med Biol; 2007 Feb; 33(2):235-45. PubMed ID: 17306694
[TBL] [Abstract][Full Text] [Related]
8. CT perfusion as an imaging biomarker in monitoring response to neoadjuvant bevacizumab and radiation in soft-tissue sarcomas: comparison with tumor morphology, circulating and tumor biomarkers, and gene expression.
Kambadakone A; Yoon SS; Kim TM; Karl DL; Duda DG; DeLaney TF; Sahani DV
AJR Am J Roentgenol; 2015 Jan; 204(1):W11-8. PubMed ID: 25539263
[TBL] [Abstract][Full Text] [Related]
9. CT perfusion for determination of pharmacologically mediated blood flow changes in an animal tumor model.
Hakimé A; Peddi H; Hines-Peralta AU; Wilcox CJ; Kruskal J; Lin S; de Baere T; Raptopoulos VD; Goldberg SN
Radiology; 2007 Jun; 243(3):712-9. PubMed ID: 17517930
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice.
Ren Y; Fleischmann D; Foygel K; Molvin L; Lutz AM; Koong AC; Jeffrey RB; Tian L; Willmann JK
Invest Radiol; 2012 Jan; 47(1):25-32. PubMed ID: 22178893
[TBL] [Abstract][Full Text] [Related]
11. Perfusion MRI for monitoring the effect of sorafenib on experimental prostate carcinoma: a validation study.
Cyran CC; Paprottka PM; Schwarz B; Sourbron S; Ingrisch M; von Einem J; Pietsch H; Dietrich O; Hinkel R; Bruns CJ; Reiser MF; Wintersperger BJ; Nikolaou K
AJR Am J Roentgenol; 2012 Feb; 198(2):384-91. PubMed ID: 22268182
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of sunitinib or sorafenib in patients with metastatic renal cell carcinoma who received prior antiangiogenic therapy.
Tamaskar I; Garcia JA; Elson P; Wood L; Mekhail T; Dreicer R; Rini BI; Bukowski RM
J Urol; 2008 Jan; 179(1):81-6; discussion 86. PubMed ID: 17997441
[TBL] [Abstract][Full Text] [Related]
13. Perfusion parameters as potential imaging biomarkers for the early prediction of radiotherapy response in a rat tumor model.
Lee HY; Kim N; Goo JM; Chie EK; Song HJ
Diagn Interv Radiol; 2016; 22(3):231-40. PubMed ID: 27023149
[TBL] [Abstract][Full Text] [Related]
14. FN13762 murine breast cancer: region-by-region correlation of first-pass perfusion CT indexes with histologic vascular parameters.
Park CM; Goo JM; Lee HJ; Kim MA; Kim HC; Kim KG; Lee CH; Im JG
Radiology; 2009 Jun; 251(3):721-30. PubMed ID: 19474375
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?
Lind JS; Meijerink MR; Dingemans AM; van Kuijk C; Ollers MC; de Ruysscher D; Postmus PE; Smit EF
Eur Radiol; 2010 Dec; 20(12):2890-8. PubMed ID: 20625738
[TBL] [Abstract][Full Text] [Related]
16. Functional CT for quantifying tumor perfusion in antiangiogenic therapy in a rat model.
Kan Z; Phongkitkarun S; Kobayashi S; Tang Y; Ellis LM; Lee TY; Charnsangavej C
Radiology; 2005 Oct; 237(1):151-8. PubMed ID: 16183931
[TBL] [Abstract][Full Text] [Related]
17. Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments.
Leguerney I; Lassau N; Koscielny S; Rodrigues M; Massard C; Rouffiac V; Benatsou B; Thalmensi J; Bawa O; Opolon P; Peronneau P; Roche A
Invest New Drugs; 2012 Feb; 30(1):144-56. PubMed ID: 20924644
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models.
Chang YS; Adnane J; Trail PA; Levy J; Henderson A; Xue D; Bortolon E; Ichetovkin M; Chen C; McNabola A; Wilkie D; Carter CA; Taylor IC; Lynch M; Wilhelm S
Cancer Chemother Pharmacol; 2007 Apr; 59(5):561-74. PubMed ID: 17160391
[TBL] [Abstract][Full Text] [Related]
19. Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy.
Azad NS; Annunziata CM; Steinberg SM; Minasian L; Premkumar A; Chow C; Kotz HL; Kohn EC
Cancer; 2008 Apr; 112(8):1726-32. PubMed ID: 18300236
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the relationship between MR estimates of blood oxygen saturation and hypoxia: effect of an antiangiogenic treatment on a gliosarcoma model.
Lemasson B; Christen T; Serduc R; Maisin C; Bouchet A; Le Duc G; Rémy C; Barbier EL
Radiology; 2012 Dec; 265(3):743-52. PubMed ID: 22996750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
